Industry Guide
Medical Devices / MedTech: Business Valuation & Sale Guide
Medical device and MedTech companies are valued around their regulatory moat as much as their financials — an FDA-cleared or approved product with a defensible IP position is worth substantially more than the same underlying technology without clearance, because clearance and IP are what keep a competitor from simply copying the product.
How Medical Devices / MedTech Companies Are Valued
Smaller device manufacturers are typically assessed on SDE, while businesses with a quality-system and regulatory-affairs function are more naturally evaluated on normalized EBITDA. A buyer reviews FDA regulatory pathway and clearance status (510(k), De Novo, or PMA), patent and IP protection, quality-system compliance (ISO 13485/QSR) history, and customer concentration among hospital systems, distributors, or group purchasing organizations.
OwnerGauge applies a provisional medical-devices-specific multiple range to the assessment, based on its own analysis of public 2025-2026 market research — the category is manufacturing-adjacent but carries an IP and regulatory-moat premium over general specialty manufacturing, provided clearance status and quality-system compliance hold up under diligence.
Typical Multiple Range
3.0x–4.3x
SDE
5.0x–8.0x
EBITDA
Manufacturing-adjacent with an IP/regulatory-moat premium over general specialty manufacturing.
This is OwnerGauge's own directional analysis of public market research for Medical Devices / MedTech — not a cited institutional transaction dataset. Your specific range depends on your company's size, quality, and risk profile. See our methodology →
Revenue Quality in Medical Devices / MedTech
- A cleared or approved device with supporting clinical evidence carries real, durable economic value beyond the underlying technology — buyers price the regulatory moat, not just the product.
- Revenue tied to reimbursed procedures with established CPT codes is more durable than revenue dependent on off-label use or uncertain reimbursement.
- Distributor or GPO-driven revenue can bring volume but often at thinner margin and with less direct customer-relationship control than direct sales.
Owner Dependency
- The founder is often the person who holds the core regulatory and clinical relationships, and may be the named inventor on key patents.
- A buyer tests whether regulatory affairs, quality systems, and key clinical relationships extend beyond the founder.
Management & Workforce
- Regulatory affairs and quality-system expertise is specialized and scarce, and a lapse in quality-system compliance can jeopardize clearance status itself.
- Buyers look for a documented quality-management system, regulatory-affairs leadership, and manufacturing/supply-chain redundancy beyond the founder.
What Can Make the Business More Attractive
- Expand or strengthen patent and IP protection around the core product
- Pursue additional indications or reimbursement codes to broaden addressable use
- Document quality-system compliance and resolve any audit findings
- Diversify customer concentration among hospital systems, distributors, and GPOs
What Can Influence Valuation
- FDA regulatory pathway and clearance/approval status
- Patent and intellectual-property protection
- Quality-system compliance history (ISO 13485/QSR) and any audit findings
- Reimbursement and CPT-code coverage supporting adoption
- Customer concentration among hospital systems, distributors, or GPOs
What Buyers May Evaluate
- Regulatory pathway, clearance status, and any pending submissions
- Patent protection, freedom-to-operate, and IP litigation history
- Quality-system audit history and any FDA warning letters or 483 observations
- Reimbursement coverage and customer/distributor concentration
Common Transaction Risks
- Clearance or approval status is narrower than the sales pipeline assumes
- Patent protection is weak, expiring soon, or contested
- Open FDA warning letters, 483 observations, or unresolved quality-system findings
- Revenue is concentrated in a small number of distributors, GPOs, or hospital systems
Preparing the Company for Sale
- Confirm and document regulatory clearance/approval status and any pending submissions
- Review patent protection and freedom-to-operate before going to market
- Resolve any open quality-system or FDA compliance findings
- Diversify customer and distributor concentration where feasible
Related reading
The value drivers above are covered in more depth here.
- Owner Dependency: Why It's the Single Biggest Lever on Your Valuation
- Customer Concentration: Why Buyers Draw the Line Around 20%
- Recurring Revenue: Why Buyers Pay More for Revenue That Doesn't Have to Be Re-Earned
- SDE vs. EBITDA: Which One Actually Matters for Your Business?
- How EBITDA Multiples Actually Work
- What Happens During Due Diligence When You Sell a Business?
How the Sale Process Works
Every sale moves through the same general stages — preparation, valuation, positioning, marketing, buyer outreach, indications of interest, a letter of intent, due diligence, definitive documentation, and closing.
See the full process →Frequently Asked Questions
How much is a Medical Devices / MedTech business worth?
Most Medical Devices / MedTech businesses trade in a range of roughly 3.0x–4.3x seller's discretionary earnings (SDE) — or roughly 5.0x–8.0x adjusted EBITDA. This range is OwnerGauge's own directional analysis of public market research, not a cited institutional transaction dataset. Where a specific company lands inside that range depends on its size, earnings quality, customer mix, and how dependent the business is on its owner. A directional estimate for your own company takes a few minutes through OwnerGauge's free assessment.
What multiple do Medical Devices / MedTech businesses sell for?
Smaller, owner-operated companies are usually assessed on SDE (about 3.0x–4.3x), while larger businesses with a management team in place are more often valued on adjusted EBITDA (about 5.0x–8.0x). The multiple itself is not a fixed number — it moves with earnings quality, growth, recurring revenue, and risk. Two businesses with identical earnings can be valued very differently.
What do buyers look for when buying a Medical Devices / MedTech business?
Buyers of Medical Devices / MedTech companies typically evaluate regulatory pathway, clearance status, and any pending submissions, patent protection, freedom-to-operate, and IP litigation history, quality-system audit history and any FDA warning letters or 483 observations, and reimbursement coverage and customer/distributor concentration. Most of a buyer's diligence is aimed at one question: how much of the current earnings will still be there after the owner leaves.
What lowers the value of a Medical Devices / MedTech business?
The most common value and deal-risk issues in this sector are clearance or approval status is narrower than the sales pipeline assumes, patent protection is weak, expiring soon, or contested, open FDA warning letters, 483 observations, or unresolved quality-system findings, and revenue is concentrated in a small number of distributors, GPOs, or hospital systems. These rarely stop a sale outright, but they show up as a lower multiple, a larger earnout, or more of the price held back in escrow.
How do I prepare a Medical Devices / MedTech business for sale?
Practical preparation for a Medical Devices / MedTech business usually means confirm and document regulatory clearance/approval status and any pending submissions, review patent protection and freedom-to-operate before going to market, resolve any open quality-system or FDA compliance findings, and diversify customer and distributor concentration where feasible. Most of this work takes 12–24 months to show up in the financial record a buyer reviews, which is why preparation is worth starting well before you intend to go to market.
How long does it take to sell a Medical Devices / MedTech business?
A prepared lower-middle-market business typically takes about 6–12 months from going to market to closing, and preparation before that often takes longer than the sale itself. The stages — preparation, valuation, positioning, marketing, buyer outreach, letter of intent, due diligence, and closing — are the same across industries; how long each takes depends largely on how ready the financial records and management structure are.
Curious what your Medical Devices / MedTech business could be worth?
Estimate your market value and see how prepared your business looks for a sale.
Estimate Your Medical Device Company Value & Deal Readiness